Evaluation of anti-mullerian hormone (AMH) cut-off levels in as-sisted reproductive technology (ART) as predictive factor for individualization ofstimulation protocols and to avoid ovarian hyperstimulation syndrome (OHSS). Here, AMH is linked to ovarian hyperstimulation syndrome.